A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.

Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred ...

Providence Alaska Medical Center (PAMC) has been certified as a Comprehensive Stroke Center by DNV, marking the highest level ...

After adjusting for pre-stroke cognition, college-educated stroke survivors had a sharper post-stroke drop in executive function over 4 years compared with those who did not complete high school, ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.

The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the ...

Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...

A new study has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke ...